United states - Events
Featured Events
27-Jan-2026 - 29-Jan-2026
Featured
Drawing on a decade of industry experience, the 10th Microbiome Movement Summit Europe returns to London, as the premiere touchpoint for end-to-end discussions in advancing best-in-class microbiome products beyond traditional gastrointestinal indications.
Over the past 10 years, this community has developed robust and impactful preclinical research, now the focus has shifted to translating this into clinical efficacy and driving towards commercial excellence, in spite of industry headwinds.
Join senior stakeholders from across the microbiome field, including drug developers, academics, consumer health, pharma, investors, service providers and more, to overcome shared challenges, spotlight innovations and collaborate in shaping the future of microbiome therapeutics.
Celebrate 10 Years of Eu…
Events
Kick off 2026 and set the tone for the year at 18th Annual Pre-Filled Syringes and Injectable Drug Devices Conference!
Join us in London on the 13th - 15th January 2026 where we will unite leaders and innovators from the device development industry. This highly anticipated conference offers unparalleled opportunities to explore the latest advances in combination product technology, share insights, and foster collaboration across a dynamic three-day program.
As part of SAE's leading Injectable Drug Delivery Series, the event features:
- Pre-Conference Focus Day: PFS Design for Enhanced Drug Delivery- Two-Day Main Conference: Morning keynote plenaries and afternoon parallel topic streams addressing the industry's most pressing challenges, including:- Large-Volume Drug Delivery Solutions- Sus…
Discover, Develop and Selectively Deliver Highly Stable and Potent RNAi Therapeutics for Targeted and Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders and Beyond
The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum for translating the next wave of siRNA and microRNA drugs from bench to bedside. As the only event uniting the entire RNAi ecosystem from discovery and complex chemistry to clinical development and CMC, this Summit provides an unparalleled platform to tackle the field's most pressing challenge: delivery beyond the liver. This is your unique opportunity to join 80+ senior leaders from pharma and biotech to gain the data-driven insights and high-value connections needed to overcome stability challenges, de-risk clinical translation,…
27-Jan-2026 - 29-Jan-2026
Enabling Rapid Target Selection, Discovery and Rational Design of Degrading and Non-Degrading Molecular Glue to Develop Potent, Selective and Safer Cures for Cancer and Beyond.
Molecular glues are leading the charge in the race to drug the previously undruggable, and 2025 has seen continued investment and partnerships driving innovation in this field. Returning as the industry’s only dedicated meeting, the 4th Molecular Glue Drug Development Summit brings top experts from biopharma and academia together for intimate networking and scientific content sharing. Designed to address the unique challenges of molecular glues, this meeting will provide actionable strategies to accelerate the development of safer, more selective candidates toward the clinic.
If you’re looking to lead the way in the…
Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel DDR targets like ATR, CHK1/2, DNA-PK, and WEE1, alongside smarter biomarker strategies and combination approaches.
This year's summit is your opportunity to stay ahead of the curve. Across three content-rich days, you'll uncover translational breakthroughs, hear from biotech innovators and academic pioneers, and gain strategic insights to overcome resistance, enhance selectivity, and accelerate clinical success. With the DDR landscape rapidly expanding, now is the time to connect, collaborate, and shape the future of targeted o…
27-Jan-2026 - 29-Jan-2026
Featured
Drawing on a decade of industry experience, the 10th Microbiome Movement Summit Europe returns to London, as the premiere touchpoint for end-to-end discussions in advancing best-in-class microbiome products beyond traditional gastrointestinal indications.
Over the past 10 years, this community has developed robust and impactful preclinical research, now the focus has shifted to translating this into clinical efficacy and driving towards commercial excellence, in spite of industry headwinds.
Join senior stakeholders from across the microbiome field, including drug developers, academics, consumer health, pharma, investors, service providers and more, to overcome shared challenges, spotlight innovations and collaborate in shaping the future of microbiome therapeutics.
Celebrate 10 Years of Eu…
For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market.
Whether advancing NaV-targeting drugs or pursuing novel pain mechanisms, non-opioid therapeutics are now in the clinical spotlight and the next 12 months promise to be transformative.
The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness that momentum. Attendees will be learning from companies with approvals such as Tonix, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join 70+ discovery, preclinical, translatio…
Inspection Readiness 360 unites clinical operations, TMF, quality, and regulatory leaders for two days of expert insights, case studies, and strategies to ensure your organization is inspection-ready in any environment.
Date and Time: On Tue, 27 Jan 2026 09:00 - Wed, 28 Jan 2026 17:00
Venue Details: Convene Two Commerce Square, 2001 Market Street, Philadelphia, Pennsylvania, 19103, United States
Category: Conferences | Science, Health and Medicine
Discover how AI is transforming medical affairs at the 5th Annual AI in Medical Affairs, taking place January 27-28, 2026, in Philadelphia, PA.Join pharmaceutical, biotech, and medical device leaders to explore real-world AI applications, innovative strategies, and compliance best practices.Engage in expert panels, case studies, and networking to gain actionable insights that enhance content creation, optimize field medical operations, and drive impactful stakeholder engagement.
Time: 9:00 AM - 5:00 PM
Venue Details: Convene Two Commerce Square, 2001 Market Street, Philadelphia, Pennsylvania, 19103, United States
Category: Conferences | Science, Health and Medicine
Europe's leading digital pharma event is back. The 14th Annual Digital Pharma Advances Conference returns to the Grand Connaught Rooms, London, uniting 35+ senior executives from 13 of the world's top 20 pharmaceutical companies — including AstraZeneca, Pfizer, Novartis, Novo Nordisk, GSK, Teva, Bayer, and Roche — to explore practical AI applications, omnichannel marketing strategies, HCP engagement, and patient-centric approaches.
Key Themes:
AI and digital innovation in pharma
Omnichannel marketing strategies
HCP engagement and digital experience
Patient-centric and personalised approaches
Actionable insights from top pharma leaders
Who Should Attend:Pharma marketing, digital, commercial, brand, patient engagement, innovation, and transformation leaders seeking prac…
03-Feb-2026 - 05-Feb-2026
The 10th Liquid Biopsy for Precision Oncology Summit is the leading annual meeting for pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy.
Now in its 10th year, this meeting delivers unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline - from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption.
If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in your conference calendar. Across ctDNA…
With Novartis committing $750M to ProFound Therapeutics to discover new cardiovascular candidates, and Illumina acquiring SomaLogic for $425 to expand its proteomic capabilities just this year alone, the increasing recognition of proteomics as a transformative force in drug discovery is unquestionable.
Returning to Boston for its second year, the Proteomics-Based Drug Discovery Summit is the premier industry event dedicated to harnessing the full power of proteomics across drug discovery pipelines. Designed for scientific innovators like you, explore how next-generation proteomic platforms are accelerating understanding of pathology, unveiling novel drug targets, and transforming hit-to-lead development.
With a special focus on optimizing proteomics instruments to balance throughput and se…
The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanemab and Donanemab, the field needs to navigate the move towards disease-modifying therapeutics.
Capitalizing on the surge of innovation across new targets, lessons learned from clinical setbacks, groundbreaking progress in blood-based diagnostics, and more, the 14th Alzheimer’s and Parkinson’s Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical and regulatory.
URLs:Tickets: https://go.evvnt.com/3259347-2?pid=185&n…
Join us at the forefront of innovation at the Marcus Evans 15th Edition R&D and Innovation Excellence Forum, where industry leaders will explore the latest strategies to optimise investments, streamline decision-making, and accelerate transformation in R&D and Innovation. Dive into practical insights on balancing portfolios, maximising ROI, and aligning innovation with market demands. This event is your gateway to understanding how to drive efficiency, foster cross-functional collaboration, and refine R&D and Innovation processes to stay ahead in an increasingly competitive landscape. Don't miss out on this opportunity to empower your R&D team with the tools and knowledge to thrive in a rapidly evolving market.
Key Topics Include:
Achieving Operational Excellence in…
The Pharma Market Research Conference East (February 4-5, 2026, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives.
The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.
For more information, please go to http://pharmamarketresearchconference.com/ , call +1-212-228-7974, or email info@pharmamarketresearchconference.com
Critical Issues America2026 Annual Conference - February 6-7, 2026We invite you to attend our annual CRITICAL ISSUES america (CIA) meeting. The meeting will help participants to identify and manage complications associated with endovascular and open repair of complex aortic disease including: arch descending thoracic, TAAA, pararenal and juxtarenal aneurysms, aortoiliac aneurysms and other miscellaneous pathologies affecting the aorta.
CIA will recognize potential treatment failure and the role of advance imaging techniques in the evaluation, treatment, and management of aortic disease.
The target audience includes physicians who specialize in vascular surgery, cardiology, interventional radiology, vascular medicine, cardiothoracic surgery, as well as fellows, and allied health professiona…
Innovating Novel Combination Therapies and Maximising Preclinical and Clinical Development to Improve Glioblastoma Targeting and Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in NeedThe glioblastoma drug development space has been energized by Merck's acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged by limited investment and clinical breakthroughs.
Looking ahead to 2026, it's crucial to sustain this momentum. The 7th Glioblastoma Drug Development Summit is your essential platform for accelerating new treatments and continuing this vital progress.
Join us for a definitive, 3-day summit designed to accelerate progress. With groundbreaking content and six deep-dive workshops, you'll connec…
The 20th Clinical Research Billing Compliance Summit brings together compliance officers, billing specialists, and research leaders to share strategies, updates, and best practices for accurate, audit-ready billing. Learn from experts, join workshops, and network with peers February 23-25, 2026 in New Orleans.
Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Clinical
Date and Time: 23rd February 2026 at 9:00 am to 25th February 2026 at 5:00 pm
Venue details: New Orleans Marriott Warehouse Arts District, 859 Convention Center Boulevard, New Orleans, Louisiana, 70130, United States
Uniting 100+ leaders from cutting-edge biotechs to global pharma, this summit delivers comprehensive insight across antigen selection, biomarker strategy, B-cell and cellular tolerance mechanisms, delivery platforms, and clinical trial execution.
The 2026 agenda spotlights late-stage data from Topas, Diamyd, and COUR; novel mRNA- LNP approaches from Moderna; integrated nanotherapeutics; and next-generation Treg and tolerance-restoring strategies. Key sessions explore central versus peripheral tolerance, and how gene and cell therapy are redefining therapeutic durability and safety.
Now in its ninth year, the 9th Antigen-Specific Immune Tolerance Summit remains the only end-to-end meeting dedicated to advancing antigen-specific immune tolerance. Join Pfizer, Moderna, AbbVie, Diamyd, COUR, a…
SAE Media Group's AI in Drug Discovery 2026 takes place 9–10 March in London. Join pharma and biotech leaders to explore how AI, ML, and generative tools are transforming drug pipelines. The agenda features case studies, clinical updates, and expert panels on target ID, computational design, and scaling AI across R and D. Discover the latest breakthroughs and connect with directors and heads of informatics, molecular design, and data science.
Date and Time: On Monday March 09, 2026 at 8:30 am to Tuesday March 10, 2026 at 6:00 pm
Venue details: Hilton London Kensington, 179-199 Holland Park Avenue, London, England, W11 4UL, United Kingdom
The 6th TPD and Induced Proximity Summit Europe is the only European forum dedicated exclusively to proximity-based drug discovery. From PROTACs and molecular glues to stabilizers and extracellular degraders, this summit showcases the full spectrum of therapeutic innovation across oncology, neurodegeneration, immunology, and rare diseases. Held in London in March 2026, the event brings together more than 80 CxOs, directors, senior scientists and investors to accelerate proximity therapeutics from discovery to clinic.
Europe is experiencing a surge in strategic investment and innovation, including Sanofi’s acquisition of Blueprint Medicines for £7.2 billion and Merck’s £2.7 billion purchase of SpringWorks Therapeutics. As the region pivots toward non-oncology indications and novel mechanism…
